ReviewInternational journal of dermatology2025
Unlocking Longevity in Aesthetic Dermatology: Epigenetics, Aging, and Personalized Care.
Review in International journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Targeting cellular senescence in dermatology: senolytic and senomorphic strategies.GeroScience · 2026Review
- Molecular Targets in Modern Cosmetic Science.Molecules (Basel, Switzerland) · 2026Review
- Epigenetic Skin Aging and Its Reversal to Improve Skin Longevity across Ethnicities and Phototypes Using a Dihydromyricetin-Containing Serum: Results from a Prospective, Single-Cohort Study.Dermatology and therapy · 2026Article
- Integrative Dermatology for Longevity: The Synergy of Topical and Internal Approaches.Dermatology and therapy · 2026Review
- Skin as a sentinel and modulator of systemic aging: a translational framework for evidence-based gerotherapeutics.GeroScience · 2026Review
- Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity.Journal of cosmetic dermatology · 2026Article
- Toward new clinical evaluation models for skin longevity: the need for predictive and accelerated approaches.GeroScience · 2026Article
- The impact of the six pillars of lifestyle medicine on the biology of skin aging.Frontiers in aging · 2026Review
- From skin aging biomarkers to precision esthetic longevity: a translational diagnostic framework.Frontiers in medicine · 2026Article
- Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin-Centered Interventions.Journal of cosmetic dermatology · 2026Article
- A State-of-the-Art Overview on (Epi)Genomics and Personalized Skin Rejuvenating Strategies.Pharmaceutics · 2025Review
- Novel Perspectives in Aesthetic Dermatology: Focusing on Epigenetics.International journal of dermatology · 2025Article
- Lifespan, Healthspan, and the Expanding Role of Cosmetic Dermatology in Longevity Science.Journal of cosmetic dermatology · 2025Article
- Advances in Longevity: The Intersection of Regenerative Medicine and Cosmetic Dermatology.Journal of cosmetic dermatology · 2025Review
- Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging.Stem cells international · 2025Review
- Epigenetic Clocks in Skin Aging: From Exposome Drivers to Biomarkers and Therapeutic Interventions.Clinical, cosmetic and investigational dermatology · 2025Review
- The interplay of cellular senescence and reprogramming shapes the biological landscape of aging and cancer revealing novel therapeutic avenues.Frontiers in cell and developmental biology · 2025Review
- Predictive Biomarkers: A New Frontier in Bespoke Aesthetic Dermatology.Aesthetic surgery journal. Open forum · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept of aging has evolved from being primarily attributed to genetic factors to recognizing the critical role of epigenetic mechanisms. Recent advancements, such as epigenetic clocks, have provided tools to assess biological age and offer insights into aging processes at the molecular level. In aesthetic dermatology, understanding these processes allows for more personalized, effective interventions targeting the root causes of skin aging. This review explores the interplay of epigenetic changes, aging, and the potential of personalized care to enhance longevity and skin rejuvenation. This review is based on an extensive literature search conducted across PubMed and other scientific databases. Studies focused on epigenetic mechanisms such as DNA methylation, histone modifications, and their relationship to skin aging. Particular attention was given to recent advancements in biological clocks, including Horvath's Clock and GrimAge, and their implications for personalized dermatological treatments. Epigenetic clocks, such as Horvath's Clock, have demonstrated utility in assessing biological age through methylation markers, revealing actionable insights into aging processes. Energy-based devices like fractional lasers and radiofrequency have shown promise in reversing age-related epigenetic changes, promoting collagen synthesis, and reducing biological skin age. Additionally, lifestyle factors such as diet, sleep, and circadian rhythm alignment significantly influence epigenetic aging and skin health. Integrating epigenetic insights into aesthetic dermatology represents a paradigm shift in skin rejuvenation, allowing for personalized treatments that address visible signs of aging and underlying molecular mechanisms. Using biological clocks provides a framework for tailoring interventions to individual patient needs, optimizing outcomes, and extending the longevity of aesthetic results. Future research should focus on longitudinal studies, accessibility, and ethical considerations to fully harness the potential of epigenetics in promoting skin health and overall well-being.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.